New hope for young transplant patients: drug combo may prevent deadly immune attack
Disease control
Not yet recruiting
This study tests whether adding the drug vorinostat to standard medications can prevent graft-versus-host disease (GVHD) in children and young adults (ages 1-26) with non-cancerous blood or immune disorders who receive a bone marrow transplant. About 55 participants will receive …
Phase: PHASE2 • Sponsor: Sung Won Choi • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC